Search Results 511-520 of 17289 for Bulimia
We're going to be doing a type of swallowing evaluation where we put a camera in your nose. We give you different consistencies of food items to swallow and ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
The purpose of this study is to determine the efficacy of pembrolizumab in patients with advanced sarcomas. Participation eligibility. Participant eligibility ...
The study will include a Phase 1 part to determine the recommended dose of JCARH125 in subjects with relapsed and/or refractory multiple myeloma, followed by a ...
Biological therapies such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Sometimes the cancer may not ...
The purpose of this study is to assess the effectiveness and safety of pembrolizumab (MK-3475) for the treatment of women with advanced ovarian cancer who have ...
About this study. The primary objective of this program is to provide Daclatasvir (DCV) for 24 weeks to be given in combination with Sofosbuvir (SOF) to ...
View faculty and staff of the Irritable Bowel Syndrome Lab of Yuri A. Saito Loftus, M.D., at Mayo Clinic's campus in Minnesota.
The objective of this study is to compare the central neural circuitry with fMRI (7T) in 30 asymptomatic healthy controls, 30 constipated patients without ...
Our study objective is to examine the implementation and effectiveness of an integrated behavioral safety delivery platform (ProActive) in clinical practice.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.